Merck
MRK
#48
Rank
โ‚น26.301 T
Marketcap
โ‚น10,530
Share price
2.96%
Change (1 day)
24.21%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): โ‚น657.78

According to Merck's latest financial reports the company's current EPS (TTM) is โ‚น685.03. In 2024 the company made an earnings per share (EPS) of โ‚น609.74 an increase over its 2023 EPS that were of โ‚น13.83.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น657.787.88%
2024โ‚น609.744308.46%
2023โ‚น13.83-97.32%
2022โ‚น516.9010.92%
2021โ‚น466.0184.68%
2020โ‚น252.34-27.2%
2019โ‚น346.6163.44%
2018โ‚น212.06151.11%
2017โ‚น84.45-54.58%
2016โ‚น185.9130.21%
2015โ‚น142.78-61.99%
2014โ‚น375.60180.51%
2013โ‚น133.90-31.82%
2012โ‚น196.396.62%
2011โ‚น184.19

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น941.73 37.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น663.94-3.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น155.16-77.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น726.82 6.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น1,851 170.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,175 71.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น334.29-51.20%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น267.92-60.89%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น324.39-52.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚น56.83-91.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel